X4 Pharmaceuticals (XFOR) Inventory (2024 - 2026)

X4 Pharmaceuticals (XFOR) has reported Inventory for 3 consecutive years, with $5.5 million the latest figure, recorded in Q2 2026.

• For the quarter ending Q2 2026, Inventory rose 73.56% year-over-year to $5.5 million; the trailing twelve-month figure through Jun 2026 stood at $5.5 million (up 73.56% YoY), and the FY2025 full-year result was $4.5 million, up 59.0% from the prior year.
• Inventory rose to $5.5 million in Q2 2026 per XFOR's latest filing, from $4.6 million in the prior quarter.
• Across five years, Inventory topped out at $5.5 million in Q2 2026 and bottomed at $831000.0 in Q2 2024.
• Historically, Inventory has averaged $3.4 million across 3 years, with a median of $3.2 million in 2025.
• The sharpest annual moves came in 2025 and 2026: Inventory soared 281.47% in 2025, then surged 50.11% in 2026.
• Over 3 years, Inventory stood at $2.8 million in 2024, then jumped by 59.0% to $4.5 million in 2025, then advanced by 22.84% to $5.5 million in 2026.
• According to Business Quant data, Inventory over the past three periods registered $5.5 million, $4.6 million, and $4.5 million for Q2 2026, Q1 2026, and Q4 2025 respectively.